Zydus Launches Affordable Transplant Drug, Avanti Feeds Soars, and Adani Wilmar Strengthens FMCG Play

Market Snapshot

• Indian benchmark indices rebounded sharply, with Nifty closing above 22,300, snapping a 10-day losing streak.
• The rally was supported by positive cues from Asian and European markets.
• Broad-based buying across sectors drove the recovery.
• All sectoral indices ended in the green, with PSU Bank, Media, Telecom, Metal, and Power indices rising 3% each.

Sectoral Trends

Top News

• Zydus Lifesciences received USFDA approval to manufacture and market Dasatinib tablets for leukemia treatment in the US, while in India, it launched ANVIMO (Letermovir) to prevent Cytomegalovirus (CMV) infections in transplant patients, addressing a critical need with a more affordable alternative.
• Avanti Feeds surged 10% to a 52-week high of ₹810 after its subsidiary Avanti Pet Care Pvt. Ltd. entered the pet food segment with the launch of “Avant Frust,” while IIFL Facilities Services acquired a 4.39% stake in the company from Thai Union Asia Investment Holding.
• Adani Wilmar shares rose 6% to ₹254.5 after announcing the phased acquisition of GD Foods Manufacturing, the company behind the ‘Tops’ brand, strengthening its position in the fast-growing FMCG sector.

Top Gainers and Losers

Trade Ideas Update

• Our trade ideas success rate has 48% over the past month, even with increased volatility in the benchmark index. Follow Trade Ideas for timely stock insights.